The Business Research Company’s global market reports are now updated with the latest market sizing information for the year 2023 and forecasted to 2032

The Business Research Company’s immunohematology market report forecasts the immunohematology market size to grow to $2.8 Billion by 2027, with a CAGR (compound annual growth rate) of 5%.

Learn More On The Immunohematology Market Report 2023 – https://www.thebusinessresearchcompany.com/report/immunohematology-global-market-report

Immunohematology Market Size Forecast
The global immunohematology market is expected to grow from $2.23 billion in 2022 to $2.34 billion in 2023 at a compound annual growth rate (CAGR) of 4.9%. The Russia-Ukraine war disrupted the chances of global economic recovery from the COVID-19 pandemic, at least in the short term. The war between these two countries has led to economic sanctions on multiple countries, a surge in commodity prices, and supply chain disruptions, causing inflation across goods and services and affecting many markets across the globe. The global immunohematology market size is expected to reach $2.8 billion in 2027 at a CAGR of 5.0%.

North America held the largest immunohematology market share, and Asia-Pacific was the fastest-growing region in 2022.

Key Immunohematology Market Driver ­– Rise In The Prevalence Rate Of Hematological Disorders
For example, according to Cancer Research UK, a UK-based research organisation, the average number of new leukaemia cases caused by haematological disorders in the UK in 2020 is predicted to rise from approximately 12,400 cases in 2023-2025 to approximately 14,500 cases in 2038-2040. As a result, the increased prevalence of haematological illnesses is propelling the immunohematology market forward.

Request for A Sample Of The Global Immunohematology Market Report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=10295&type=smp

Key Immunohematology Market Trend – Technological Advancement
To maintain their market position, major immunohematology companies are focusing on developing breakthrough technology. For example, in October 2021, Ortho Clinical Diagnostics, a diagnostics firm based in the United States, announced the release of additional features for its Immediate Spin Crossmatch (ISXM) system for ORTHO VISION and ORTHO VISION MAX Analyzers. The ISXM system is a complete transfusion solution that integrates a number of devices and software programmes to expedite and automate immunohematology testing and processing. In blood transfusions, ISXM is used to detect ABO blood type incompatibility between recipient serum and plasma and donor red blood cells. Despite the fact that more laboratories are employing electronic crossmatch, many continue to use full crossmatches (AHG/IAT). In addition to a full crossmatch, an ISXM test must be completed.

Immunohematology Market Segment
1) By Product: Analyzers And Systems, Reagents
2) By Technology: Biochips, Erythrocyte-Magnetized Technology (Emt), Gel Cards, Microplates, Polymerase Chain Reaction (PCR)
3) By Disease: Blood-Related Diseases, HIV, Hepatitis
4) By Application: Pretransfusion Testing, Investigation Of Immune Hemolysis, Perinatal Testing, Blood Group Phenotyping, Leucocyte And Platelet Serology
5) By End User: Blood Banks, Diagnostic And Reference Laboratories, Hospitals, Academic And Research Institutes

Immunohematology Market Major Players and Strategies
Major players in the immunohematology market are Ortho Clinical Diagnostics, Immunocor Inc., Abbott Laboratories, Siemens Healthineers AG, Grifols S.A., Beckman Coulter Inc., Thermo Fisher Scientific Inc., Becton, Dickinson and Company, Merck KGaA, Bio-Rad Laboratories, Nihon Kohden Corporation, Sysmex Corporation, Danaher Corporation, Biosystems S.A., Roche Holdings AG, and Mindray Medical International Limited.

Werfen, S.A., a diagnostic care company based in Spain, paid nearly $2 billion for Immucor Inc. in March 2023. Werfen, S.A.’s acquisition aims to broaden its skills in specialised diagnostic testing, notably for diagnostic solutions. Immucor Inc. is a transfusion diagnostics firm established in Spain that focuses on offering blood tests that are safe, accessible, and economical.

The Immunohematology Global Market Report 2023 covers regional data on immunohematology market size, immunohematology market trends and drivers, opportunities, strategies, and immunohematology market competitor analysis. The countries covered in the immunohematology market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, the UK, and the USA, and the major seven regions are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, the Middle East, and Africa.

Immunohematology is a subspecialty of laboratory medicine that investigates blood groups and the immunological response of the body to foreign substances, particularly in blood transfusions. Immune haematological procedures are used to identify and treat diagnostic difficulties in individuals suffering from haematological diseases such as auto-immune hemolytic anaemia.

View More Reports Related To The Immunohematology Market –
Immunosuppressants Global Market Report 2023
Immunoglobulins Global Market Report 2023
Hematology Diagnostic Devices And Equipment Global Market Report 2023

Contact us at:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 3156230293
Asia +44 2071930708
Europe +44 2071930708
Email us at [email protected]

Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Found this article helpful? Share it on: